
Impact of Prolonged Impella 5.5 Support on Post-Transplant Outcomes: An Institutional Study
This institutional retrospective study evaluated 72 patients bridged to heart transplant with the Impella 5.5 and compared outcomes for support durations of 14 days or less versus more than 14 days. Prolonged support did not worsen 1-year survival, graft rejection, length of stay, or major complications. Although rehospitalization within a year was common, overall survival was excellent, supporting extended Impella 5.5 use as a safe bridge-to-transplant strategy.



